Time to read
Deborah Gold, Chief Executive of National AIDS Trust, said:
“We are delighted to see the Scottish Medicines Consortium has laid the groundwork for long-acting injectables by approving the use of cabotegravir with rilpivirine for adults living with HIV in Scotland.
“Clinical trials have already shown that this method of delivering treatment is safe and effective, and people living with HIV are highly satisfied with monthly injections compared with daily pills.
“Long-acting injectables won’t be right for everyone, but this innovation in treatment provision will be important for some. They have already been approved for use in Europe and the US, now Scotland is leading the way here. We call on the rest of the UK to follow suit.”